XOMA to Present at the 2016 Wedbush PacGrow Healthcare Conference
August 11 2016 - 2:33PM
XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and
development of therapeutic antibodies, announced today that John
Varian, the Company’s Chief Executive Officer, is scheduled to
present at the Wedbush PacGrow Healthcare Conference on Wednesday,
August 17, 2016, at 3:40 p.m. EDT.
A live audio webcast of the presentation can be
accessed in the Investors and Media section of XOMA's website at
http://investors.xoma.com/events.cfm. An archived version of the
webcast will be available via replay for 30 days following the
presentation.
About XOMA CorporationXOMA
Corporation is a leader in the discovery and development of
therapeutic antibodies. The Company's innovative product candidates
result from its expertise in developing ground-breaking monoclonal
antibodies, including allosteric antibodies, which have created new
opportunities to potentially treat a wide range of human diseases.
XOMA's scientific research has produced a portfolio of five
endocrine assets, each of which has the opportunity to address
multiple indications. The Company's lead product candidate, XOMA
358, is an allosteric monoclonal antibody that reduces insulin
receptor activity, which could have a major impact on
hyperinsulinism. The Company recently initiated Phase 2 development
activities for XOMA 358 in patients with congenital hyperinsulinism
and in patients who experience hypoglycemia following gastric
bypass surgery. For more information, visit www.xoma.com.
Company and Investor Contact:
Ashleigh Barreto
510-204-7482
barreto@xoma.com
Juliane Snowden
The Oratorium Group, LLC
jsnowden@oratoriumgroup.com
Media Contact:
Taryn Ibach
W2O Group
415-658-9748
tibach@w2ogroup.com
XOMA (NASDAQ:XOMA)
Historical Stock Chart
From Mar 2024 to Apr 2024
XOMA (NASDAQ:XOMA)
Historical Stock Chart
From Apr 2023 to Apr 2024